(Q43790314)

English

Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.

scientific article published on 30 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

based on heuristic

inferred from title

major depressive disorder

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Ahmad Ghanizadeh

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 September 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Depression and Anxiety

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1084-1088

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Association of depressive disorders, depression characteristics and antidepressant medication with inflammation

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Targeting IL-1 in depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Depressive symptoms enhance stress-induced inflammatory responses

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Proinflammatory and "resiliency" proteins in the CSF of patients with major depression.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

A comparison of inflammatory markers in depressed and nondepressed smokers.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Lovastatin decreases the synthesis of inflammatory mediators in the hippocampus and blocks the hyperthermia of rats submitted to long-lasting status epilepticus

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Chronic stress, daily stressors, and circulating inflammatory markers

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Lovastatin potentiates the antidepressant efficacy of fluoxetine in rats

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Long-term statin use and psychological well-being

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Statin use and depressive symptoms in a prospective study of community-living older persons.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Simvastatin causes changes in affective processes in elderly volunteers

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Antidepressant and statin interactions: a review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitis

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

21 January 2018

Statins to reduce risk of depression

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

7 January 2021

based on heuristic

inferred from DOI database lookup

The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of statins on mood: a review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults

1 reference

https://api.crossref.org/works/10.1002%2FDA.22195

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.22195

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24115188%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43790314&oldid=2153263133"